Search For "biotech"
Bharat Biotech's intranasal booster vaccine can be a game-changer if it pr
Updated : 4 years ago IST
New Delhi [India], March 11 (ANI): Bharat Biotech's intranasal booster vaccine can be a game-changer if it provides mucosal immunity against COVID-19, said Dr Sanjay Rai, Professor for Community Medicine at AIIMS as the clinical trials for the vaccine commenced on Friday.
Read More
AIIMS Delhi to start clinical trial of intranasal COVID-19 vaccine from Fr
Updated : 4 years ago IST
New Delhi [India], March 9 (ANI): All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials of Bharat Biotech's intranasal booster dose against COVID-19 from Friday, said sources.
Read More
COVID-19: FDA gives clearance to Covaxin for clinical trials in adults in
Updated : 4 years ago IST
New Delhi [India], March 7 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
Read More
Arbro Pharmaceuticals introduces Ningen, its Japanese and Flora Inspired C
Updated : 4 years ago IST
New Delhi [India], February 22 (ANI/NewsVoir): Arbro Pharmaceuticals, a leading Delhi-based R&D and pharmaceutical manufacturing company, has launched its cosmetic and nutraceutical line, Ningen.shop, offering a range of products containing flower, fruit, and plant extracts.
Read More
Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat Biotec
Updated : 4 years ago IST
Hyderabad (Telangana) [India], February 19 (ANI): Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.
Read More
Researchers engineer novel human spinal cord implants to treat paralysis
Updated : 4 years, 1 month ago IST
Tel Aviv [Israel], February 7 (ANI): It is an unfortunate reality that there isn't a cure for permanent paralysis. The spinal cord can't heal itself. But, now, for the first time in the world, researchers from Sagol Center for Regenerative Biotechnology at Tel Aviv University, engineered 3D
Read More
Fermenta Biotech Limited and Mextech Property Developers LLP (incorporated
Updated : 4 years, 1 month ago IST
Thane (Maharashtra) [India], February 2 (ANI/PNN): Fermenta Biotech Limited ('Fermenta') announced that it has signed a Binding Term Sheet today with Mextech Property Developers LLP ('Mextech') for the balance development of its Thane property through Mextech, whose key partners are Anil Mut
Read More
Budget outlay in health sector, vaccine self-reliance has helped biotech i
Updated : 4 years, 1 month ago IST
New Delhi [India], February 2 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Wednesday welcomed the Union Budget 2022 and said that during COVID-19 pandemic budget outlay in the healthcare sector and vaccine self-reliance has helped the biotech industry.
Read More
Zydus commences supply of COVID-19 vaccine ZyCoV-D to Central govt
Updated : 4 years, 1 month ago IST
Ahmedabad (Gujarat) [India], February 2 (ANI): Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence
Read More
Govt should prioritise to move GDP from 1.2pc to 2.5pc in healthcare: Raje
Updated : 4 years, 1 month ago IST
New Delhi [India], January 31 (ANI): Ahead of the presentation of the Union budget 2022-23 on February 1 by Union Finance Minister Nirmala Sitharaman, the healthcare industry has urged for the improvement of investments and incentivizing of capital expenditure of healthcare sector.
Read More
COVID-19: Nasal vaccine could be a game-changer if it provides mucosal imm
Updated : 4 years, 1 month ago IST
New Delhi [India], January 30 (ANI): As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay
Read More
Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials
Updated : 4 years, 1 month ago IST
New Delhi [India], January 28 (ANI): The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.
Read More